Rezolute, Inc. (RZLT)
1.965
+0.34
(+20.55%)
USD |
NASDAQ |
Dec 16, 15:02
Rezolute Research and Development Expense (Annual): 61.53M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Geron Corp. | 103.74M |
| XOMA Royalty Corp. | 2.875M |
| Sarepta Therapeutics, Inc. | 778.47M |
| Astria Therapeutics, Inc. | 77.11M |